Literaturverzeichnis

1 Singer MV, Gyr K, Sarles H. Report of the Second International Symposium on the Classification of Pancreatitis in Marseille, France, March 28-30, 1984. Gastroenterology 1985: 89; 683-5.

2 Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. N Engl J Med 1993: 328; 1433-1437.

3 Lowenfels AB, Maisonneuve P. Risk factors for cancer in hereditary pancreatitis. Med Clin North Am 2000: 84; 5565-5573.

4 Secknus R, Mössner J. denz- und Prävalenzveränderungen der akuten und chronischen Pankreatitis in Deutschland. Chirurg 2000: 71; 249-252.

5 Andersen BN, Pedersen NT, Scheel J, Worning H. Incidence of alcoholic chronic pancreatitis in Copenhagen. Scand J Gastroenterol 1982: 17; 247-252.

6 Ammann RW, Bühler H, Münch R, Freiburghaus AW, Siegenthaler W. Differences of the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients. Pancreas 1987: 2; 368-377 ..

7 Durbec JP, Sarles H. Multicenter survey on the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreatitis and alcohol, protein, and lipid consumption. Digestion 1978: 18; 337-350.

8 DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. Hrsg.: Go VLW et al.: The Pancreas: Biology, Pathobiology, and Disease New York, Raven, 1993 665-706.

9 Ammann RW. Idiopathic “juvenile” chronic pancreatitis. Dtsch Med Wochenschr 1976: 101; 1789-1794.

10 Ammann RW. Chronic pancreatitis in the elderly. Gastroenterol Clin North Am 1990: 19; 905-914.

11 Layer P, Yamamoto H, Kalthoff L, et al. The different courses of early- and late-onset idiopathic and alcoholic chronic panceatitis. Gastroenterology 1994: 107; 1481-1487.

12 Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952: 21:; 54-63.

13 Perrault J. Hereditary pancreatitis. Gastroenterol Clin North Am 1994: 23; 743-752.

14 Chiari H Über Selbstverdauung des menschlichen Pankreas. Zeitschrift für Heilkunde 1896: 17; 69-96.

15 Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med 1987: 316; 144-150.

16 Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genet 1996: 14; 141-145.

17 Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nature Genet 2000: 25; 213-216.

18 Rinderknecht H. Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 1986: 31; 314-321.

19 Whitcomb DC, Preston RA, Aston CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 1996: 110; 1975-1980.

20 Le Bodic L, Bignon JD, Raguénès O, et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet 1996: 5; 549-554.

21 Pandya A, Blanton SH, Landa B, et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. Genomics 1996: 38; 227-230.

22 Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999: 117; 7-10.

23 Pfützer RH, Barmada NM, Brunskill APJ, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000: 119; 615-623.

24 Witt H, Luck W, Becker M, et al. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001: 285; 2716-2717.

25 Drenth JPH, te Morsche R, Jansen JBMJ. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002: 50; 687-692.

26 Chandak GR, Idris MM, Reddy DN, Bhaskar S, Sriram PV, Singh L. Mutations in the pancreatic secretory trypsin inhibitor gene (PST1/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 2002: 39; 347-351.

27 Hassan Z, Mohan V, Ali L, et al. SPINK1 is a susceptibility gene for fibrocalculous pancreatic pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002: 71; 964-968.

28 Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H. Tropical calcific pancreattits: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 2002: 123; 1020-1025.

29 Schneider A, Suman A, Rossi L, et al. SPINK1/PST1 mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002: 123; 1026-1030.

30 Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. New Engl J Med 1998: 339; 645-52.

31 Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. New Engl J Med 1998: 339; 653-658.

32 Ramanan AV, Thimmarayappa AD, Baildam EM. Acute lethal pancreatitis in childhood systemic lupus erythematosus. Rheumatology 2002: 41; 467-9.

33 Kugathasan S, Halabi I, Telega G, Werlin SL. Pancreatitis as a presenting manifestation of pediatric Crohn's disease: a report of three cases. J Pediatr Gastroenterol Nutr 2002: 35; 96-8.

34 Triantafillidis JK, Cheracakis P, Merikas EG, Peros G. Acute pancreatitis may precede the clinical manifestations of Crohn's disease. Am J Gastroenterol 2003: 98; 1210-1.

35 Ichimura T, Kondo S, Ambo Y, et al. Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology 2002: 49; 1221-4.

36 Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: Case report and review. Gastrointest Endosc 2003: 57; 118-20.

37 Boudailliez B, Andre JL, Broyer M, Davin JC, Landthaler G, Palcoux JB. Acute pancreatitis in six non-transplanted uraemic children. A co-operative study from the French Society of Paediatric Nephrology. Pediatr Nephrol. 1988: 2; 431-5.

38 Grodinsky S, Telmesani A, Robson WL, Fick G, Scott RB. Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr 1990: 11; 518-24.

39 Cox DW, Breckenridge WC, Little JA. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 1978: 299; 1421-4.

40 Flink EB, Desper PC, Jones JE. Primary hyperparathyroidism causing hypercalcemic crisis and acute pancreatitis. Minn Med 1966: 49; 734-44.

41 Shwachman H, Lebenthal E, Khaw W. Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 1975: 55; 86-94.

42 Atlas AB, Orenstein SR, Orenstein DM. Pancreatitis in young children with cystic fibrosis. J Pediatr 1992: 120; 756-759.

43 del Rosario JF, Putnam PE, Orenstein DM Chronic pancreatitis in a patient with cystic fibrosis and clinical pancreatic insufficiency. J Pediatr 1995: 126; 951-952.

44 Delhaye M, Engelholm L, Cremer M. Pancreas divisum: congenital anatomic variant or anomaly? Contribution of endoscopic retrograde dorsal pancreatography. Gastroenterology 1985: 89; 951-8.

45 Richter JM, Schapiro RH, Mulley AG, Warshaw AL. Association of pancreas divisum and pancreatitis, and its treatment by sphincteroplasty of the accessory ampulla. Gastroenterology 1981: 81; 1104-10.

46 Delhaye M, Engelholm L, Cremer M. Pancreas divisum: controversial clinical significance. Dig Dis 1988: 6; 30-9.

47 Online Mendelian Inheritance in Man (OMIM): http://www.ncbi.nlm.nih.gov

48 Guy O, Lombardo D, Bartelt DC, Amic J, Figarella C. Two human trypsinogens: purification, molecular properties and N-terminal sequences. Biochemistry 1978: 17; 1669-1675.

49 Scheele GA, Bartelt D, Bieger W. Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing/SDS gel elctrophoresis. Gastroenterology 1981: 80; 461-473.

50 Colomb E, Figarella C. Comparative studies on the mechanism of activation of the two human trypsinogens. Biochem Biophys Acta 1979: 571; 343-351.

51 Colomb E, Guy O, Deprez P, Michel R, Figarella C. The two human trypsinogens: Catalytic properties of the corresponding trypsins. Biochem Biophys Acta 1978: 525; 186-193.

52 Rowen L , Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996: 272; 1755-1762.

53 Gorry MC, Gabbaizedeh D, Furey W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997: 113; 1063-1068.

54 Teich N, Mössner J, Keim V. Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mut 1998: 12; 39-43.

55 Férec C, Raguénès O, Salomon R, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999: 36; 228-232.

56 Teich N, Ockenga J, Hoffmeister A, Manns M, Mössner J, Keim V. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000: 119; 461-465.

57 Weber P, Keim V, Zimmer KP. Hereditary pancreatitis and mutation of the cationic trypsinogen gene. Arch Dis Child 1999: 80; 473-474.

58 Creighton J; Lyall R, Wilson DI, Curtis A, Charnley R. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 1999: 354; 42-43.

59 Nishimori I, Kamakura M, Fujikawa-Adachi K, et al. Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999: 44; 259-263.

60 Simon P, Weiss FU, Sahin-Toth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2002: 277; 5404-10.

61 Pfützer R, Myers E, Applebaum-Shapiro S, et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut 2002: 50; 271-2.

62 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994: 369; 64-67.

63 Higaki JN, Light A. The identification of neotrypsinogens in samples of bovine trypsinogen. Anal Biochem 1985: 148; 111-120.

64 Rovery M. Limited proteolysis in pancreatic chymotrypsinogens and trypsinogens. Biochemie 1988: 70; 1131-1135.

65 Gaborioud C Serre L, Guy-Crotte O, Forest E, Fontecilla-Camps JC. Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151. J Mol Biol 1996: 259; 995-1010.

66 Várallyay É, Pál G, Patthy A, Szilágyi L, Gráf L. Two mutations in the rat trypsin confer resistance against autolysis. Biochem Biophys Res Commun 1998: 243; 56-60.

67 Sahin-Tóth M, Gráf L, Tóth M. Trypsinogen stabilization by mutation arg117-to-his: a unifying pathomechanism for hereditary pancreatitis? Biochem Biophys Res Commun 1999: 264; 505-508.

68 Sahin-Tóth M, Tóth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun 2000: 278; 286-289.

69 Sahin-Tóth M. Hereditary pancreatitis-associated mutation Asn21 Ile stabilizes rat trypsinogen in vitro. J Biol Chem 1999: 274; 29699-29704.

70 Pfützer RH, Whitcomb DC. Trypsinogen mutations in chronic pancreatitis (letter). Gastroenterology 1999: 117; 1507-1508.

71 Chen JM, Raguénès O, Férec C, Deprez PH, Verellen-Dumoulin C, Andriulli A. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis (letter). Gastroenterology 1999: 117; 1508-1509.

72 Matthew P, Wyllie R, Caulfield M, Steffen R, Kay M. Chronic pancreatitis in late childhood and adolescence. Clin Pediatr 1994: 33; 88-94.

73 Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from the pancreas. 1948: 70; 304-340.

74 Shibata T, Ogawa M, Matsuda K, Miyauchi K, Yamamoto T, Mori T. Purification and characterisation of pancreatic secretory trypsin inhibitor in human gastric mucosa. Clin Chim Acta 1986: 159; 27-36.

75 Shibata T, Ogawa M, Takata N. Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa. Res Commun Pathol Pharmacol 1987: 55; 243-248.

76 Marchbank T, Freeman TC, Playford RJ. Human pancreatic secretory trypsin inhibitor. Digestion 1998: 59; 167-174.

77 Horii A, Kobayashi T, Tomita N, et al. Primary structure of human pancreatic secretory trypsin inhibitor (PSTI) gene. Biochem Biophys Res Commun 1987: 149; 635-641.

78 Bartelt DC, Shapanka R, Greene LJ. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Arch Biochem Biophys 1977: 179; 189-199.

79 Laskowski M, Wu FC. Temporary inhibition of trypsin. J Biol Chem 1953: 204; 797-805.

80 Chen JM, Mercier B, Audrézet MP, Férec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000: 37; 67-69.

81 Kuwata K, Hirota M, Shimizu H, et al. Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 2002: 37; 928-34.

82 Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990: 63; 827-834.

83 Marcus N, Teckman JH, Perlmutter DH. 1-antitrypsin deficiency: from genotype to childhood disease. J Pediatr Gastroenterol Nutr 1998: 27; 65-74.

84 Highsmith WE, Burch LH, Zhou Z, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease bur normal sweat chloride concentrations. New Engl J Med 1994: 331; 974-980.

85 Busslinger M, Moschonas N, Flavell RA. + thalassemia : aberrant splicing results from a single point mutation in an intron. Cell 1981: 27; 289-298.

86 Noone PG, Zhou Z, Silverman LM, et al. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001: 121; 1310-9.

87 Audrézet MP, Chen JM, Le Maréchal C, et al. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2002: 10; 100-6.

88 Witt H, Hennies HC, Becker M. SPINK1 mutations in chronic pancreatitis. Gastroenterology [letter]. 2001: 120; 1060-1.

89 Owyang C, Levitt M. Chronic pancreatitis. Hrsg.: Yamada T: Textbook of Gastroenterology 2nd Philadelphia, Lippincott, 1991 1874-1893.

90 Sveger T, Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 1995: 22; 514-517.

91 Crawford DHG, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998: 114; 1003-1008.

92 Borot N, Roth M, Malfroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997: 5; 371-375.

93 Piperno A, Sampietro M, Pietrangelo A, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998: 114; 996-1002.

94 Stamatoyannopoulos G, Woodson R, Papayannopoulou T, et al. Inclusion-body -thalassemia trait: a form of thalassemia producing clinical manifestations in simple heterozygotes. New Engl J Med 1974: 290; 939-943.

95 Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989: 245; 1066-1073.

96 Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989: 245; 1073-1080.

97 Zielenski J, Roznahel R, Bozon D, et al. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991: 10; 214-228.

98 Riordan JR. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 1993: 55; 609-630.

99 Crawford I, Maloney PC, Zeitlin PL, et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA 1991: 88; 9262-9266.

100 Harris A, Chalkley G, Goodman S, Coleman L. Expression of the cystic fibrosis gene in human development. Development 1991: 113; 305-310.

101 Marino CR, Matovcik LM, Gorelick FS, Cohn JA. Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J Clin Invest 1991: 88; 712-716.

10 2 The Cystic Fibrosis Genetic Analysis Consortium. Population variation of common cystic fibrosis mutations. Hum Mutat 1994: 4; 167-177.

103 Welsh M, Smith A. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993: 73; 1251-1254.

104 Wilschanski M, Zielenski J, Markiewicz D, et al. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations . J Pediatr 1995: 127; 705-710.

105 Arduino C, Gallo M, Brusco A, et al. Polyvariant mutant CFTR genes in patients with chronic pancreatitis. Clin Genet 1999: 56; 400-404.

106 Ockenga J, Stuhrmann M, Ballmann M, et al. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol. 2000: 95; 2061-2067.

107 Kimura S, Okabayashi Y, Inushima K, Yutsudo Y, Kasuga M. Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig Dis Sci. 2000: 45; 2007-2012.

108 Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. Gut 2001: 48; 70-74.

109 Bank S, Marks IN, Novis B. Sweat electrolytes in chronic pancreatitis. Am J Dig Dis 1978: 23; 178-181 ..

110 Nakamura K, Sarles H, Payan H. Three-dimensional reconstruction of the pancreatic ducts in chronic pancreatitis. Gastroenterology 1972: 62; 942-949.

111 de Angelis C, Valente G, Spaccapietra M, et al. Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis. Pancreas 1992: 7; 193-196.

112 Ravnik-Glavac M, Glavac D, di Sant’Agnese P, Chernick M, Dean M. Cystic fibrosis gene mutations detected in hereditary pancreatitis. Pflügers Arch 1996: 431(Suppl); R191-R192.

113 Kiesewetter S, Macek M Jr, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet 1993: 5; 274-278.

114 Perlmutter DH. Alpha-1-antitrypsin deficiency. Semin Liver Dis 1998: 18; 217-225.

115 Sharp HL, Bridges RA, Krivit W. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969: 73; 934-939.

116 Eriksson S. Pulmonary emphysema and 1-antitrypsin deficiency. Acta Med Scand 1964: 175; 197-205.

117 Brantley M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988: 84(suppl 6A); 13-31.

118 Hutch ison DCS. 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. Respir Med 1998: 92; 367-377.

119 Novis BH, Young GO, Bank S, Marks IN. Chronic pancreatitis and alpha-1-antitrypsin. Lancet 1975: ii; 748-749 ..

120 Mihas AA, Hirschowitz BI. Alpha1-antitrypsin and chronic pancreatitis. Lancet 1976: ii; 1032-1033.

121 Edmunds SEJ, Wilkinson ML. Alpha 1-antitrypsin deficiency and pancreatitis in a juvenile. Aust N Z J Med 1991: 21; 345-347.

122 Rabassa AA, Schwartz MR, Ertan A. 1-antitrypsin deficiency and chronic pancreatitis. Dig Dis Sci 1995: 40; 1997-2001.

123 Braxel C, Versieck J, Lemey G, Vanballenberghe L, Barbier F. Alpha1-antitrypsin in pancreatitis. Digestion 1982: 23; 93-96.

124 Lankisch PG, Koop H, Winckler K, Kaboth U. 1-antitrypsin in pancreatic diseases. Digestion 1978: 18; 138-140.

125 Haber PS, Wilson JS, McGarity BH, Hall W, Thomas MC, Pirola RC. 1 antitrypsin phenotypes and alcoholic pancreatitis. Gut 1991: 32; 945-948.

126 Witt H, Kage A, Luck W, Becker M. 1-antitrypsin genotypes in patients with chronic pancreatitis. Scand J Gastroenterol 2002: 37; 356-9.

127 Teich N, Walther K, Bödeker H, et al. Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol 2002: 37; 360-5.

128 Larsson C. Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978: 204; 345-351.

129 Rinderknecht H. Pancreatic secretory enzymes. Hrsg.: eds Go VLW et al: In The Pancreas: Biology, Pathobiology, and Disease 1993: New York, Raven, 219-251.

130 Laskowski M Jr, Kato I. Protein inhibitors of proteinases. Annu Rev Biochem 1980: 49; 593-626.

131 Freedman SD, Blanco P, Shea JC, Alvarez JG. Mechanisms to explain pancreatic dysfunction in cystic fibrosis. Gastroenterol Clin North Am 2000: 84; 657-664.

132 Lerch MM, Gorelick FS. Early trypsinogen activation in acute pancreatitis. Gastroenterol Clin North Am 2000: 84; 549-563.

133 Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas 1997: 14; 215-221.

134 Haber P, Wilson J, Apte M, et al. Individual susceptibility to alcoholic pancreatitis: still an enigma. J Lab Clin Med 1995: 125; 305-312.

135 Norton ID, Apte MV, Dixson H, et al. Cystic fibrosis genotypes and alcoholic pancreatitis. J Gastroenterol Hepatol 1998: 13; 496-99.

136 Teich N, Mössner J, Keim V, et al. Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis? Gut 1999: 44; 413-416.

137 Threadgold J, Greenhalf W, Ellis I, et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 2002: 50; 675-81.

138 Rinderknecht H, Stace NH, Renner IG. Effects of alcohol abuse on exocrine pancreatic secretion in man. Dig Dis Sci 1985: 50; 65-71.

139 Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984: 25; 756-9.

140 Sarles H, Adler G, Dani R, et al. The pancreatitis classification of Marseilles-Rome 1988. Scand J Gastroenterol 1989: 24; 641-2.

141 Sarles H, Adler G, Dani R, et al. Classifications of pancreatitis and definition of pancreatic diseases. Digestion 1989; 234-6.

142 Comfort MW, Gambill EE, Baggenstoss AH. Chronic relapsing pancreatitis: a study of 29 cases without associated disease of the biliary or gastrointestinal tract. Gastroenterology 1946; 239-85.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
20.05.2005